NOVO NORDISK A S (NVO) Form 6-K — Nov 9, 2026
Novo Nordisk filed a 6-K updating the market on its ongoing share repurchase programme, reporting daily buyback transactions from 3 to 6 November 2026 under the DKK 15 billion programme running from 4 February 2026. Since 4 February 2026 the company has repurchased 42,604,179 B shares at an average price of DKK 277.16, totaling DKK 11.8 billion of the DKK 15 billion authorization. Novo Nordisk now holds 56.6 million treasury B shares, about 1.3% of share capital.
Key figures
- Programme max dkk
- DKK 15 billion over 12 months from 4 February 2026
- Total shares a and b
- 4465000000
- May programme max dkk
- DKK 11,200,000,010.45 (6 May 2026 to 1 February 2027)
- Treasury shares total
- 56644876
- Ytd average price dkk
- 277.16
- Ytd transaction value dkk
- 11808013711
- Treasury pct of share capital
- 1.3%
- Accumulated programme value dkk
- 8008013722
- Shares repurchased under programme
- 27845000
- Ytd shares repurchased since 4feb2026
- 42604179
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.